AMA 2026 Survey: 81% of Physicians Use AI Daily, Global Healthcare AI Market Hits $56B, Proactive Coordinated Care Emerges as New Trend
A Milestone Survey: AI Has Become Medical Mainstream
In March 2026, the American Medical Association (AMA) released its "2026 Physician Survey on Augmented Intelligence," revealing a historic turning point: 81% of physicians now incorporate AI into their daily practices, more than doubling from 38% in 2023. This data marks AI's transformation in healthcare from an experimental tool to a fundamental workflow component.
Simultaneously, the global healthcare AI market is projected to reach $56 billion in 2026, up approximately 42% from $39.3 billion in 2025. Long-term projections are even more optimistic — analysts forecast the market will surpass $1.03 trillion by 2034, reflecting the deepening application of healthcare AI in diagnostic, pharmaceutical, and administrative tools.
Core Survey Findings
Adoption Rate and Depth of Use
The AMA survey was conducted from January 15 to February 2, 2026, with 1,692 physician respondents. Key findings include:
Breadth of Use:
- Physicians reported using an average of 2.3 AI use cases, up significantly from 1.1 in 2023
- Most common application: 39% use AI to summarize medical research and standards of care
- 30% use AI for discharge instructions, care plans, or progress notes
- 28% use AI for billing codes, medical charts, or visit notes
- 19% use AI to draft responses to patient portal messages
Attitude Shift:
- 76% of respondents reported that AI provides an advantage in patient care (up from 65% in 2023)
- 70% of physicians identify AI as a key solution to mitigating work-related burnout
Key Concerns and Barriers
Despite the significant rise in adoption, physicians retain notable concerns:
| Concern Type | Percentage |
|---|---|
| Data privacy assurances | 86% cite as critical |
| Safety and efficacy validation | 88% emphasize necessity |
| Skill loss (especially medical students and residents) | Nearly 90% express concern |
| Clear liability frameworks | Ranked as top regulatory priority |
Notably, 40% of physicians feel equally excited and concerned about AI's long-term impacts, reflecting the medical community's complex attitude toward this technology.
Proactive Coordinated Care: A New Paradigm for Healthcare AI
An industry analysis report released on October 19, 2026, further revealed the latest development trend in healthcare AI — Proactive Coordinated Care is emerging as a new paradigm for healthcare AI applications.
Why Proactive Coordinated Care?
U.S. healthcare spending reached $5.3 trillion in 2024, while chronic conditions affect three in four American adults. The traditional reactive healthcare model — waiting for patients to present symptoms before intervening — can no longer effectively address this challenge.
AI-driven proactive coordinated care transforms this situation through:
- Care Gap Identification: AI systems analyze patient data to proactively identify unmet care needs
- Personalized Health Navigation: Providing patients with customized health management recommendations and resources
- Cross-System Integration: Connecting health plans, management services, and AI technology to eliminate administrative and clinical silos
Industry Integration Cases
ECGI Holdings integrated health insurance, management services, and AI health technology through its acquisition of the Avanta Group, aiming to leverage AI for care gap identification and personalized health navigation.
UnitedHealth Group, CVS Health, Elevance Health, and Humana are evolving their Medicare Advantage models toward more connected, simplified, and proactive care experiences.
Rocket Doctor AI reported significant growth in patient visits in Q3 2026, driven by its multi-payer strategy across North America.
Technical Limitations: The Transparency Challenge
Despite significant advances in healthcare AI, Professor Thomas Thesen of Dartmouth's Geisel School of Medicine identified a fundamental challenge: AI systems are highly effective at pattern recognition but often cannot explain the underlying logic of those patterns.
This "black box" problem is particularly important in clinical decision-making. Physicians need to understand the basis for AI recommendations to responsibly incorporate them into diagnostic decisions. This is why 88% of physicians emphasize the need for rigorous safety and efficacy validation by trusted entities.
Healthcare AI Development in Asia-Pacific
Healthcare AI development in Asia-Pacific exhibits distinctive regional characteristics:
Singapore, South Korea, and Taiwan Collaboration: At HIMSS26 APAC, five digitally mature healthcare providers from these three markets signed a memorandum of understanding to establish the "HIMSS AI Outcomes Framework," aiming to re-engineer health systems through a more structured, outcomes-focused approach.
Southeast Asia's Digital-First Strategy: Markets like Malaysia are accelerating digital solutions in primary care, chronic disease management, and outpatient services.
Governance Gap: Despite rising AI usage, research indicates that organizational readiness and systemic support are, in some instances, lagging behind the speed of AI adoption — one of the main challenges facing healthcare AI development in Asia-Pacific.
Market Outlook: From $56B to $1 Trillion
The global healthcare AI market's growth trajectory is impressive:
- 2025: $39.3 billion
- 2026: $56 billion (projected)
- 2034: $1.03 trillion (forecast)
This growth is driven by multiple factors: the proliferation of AI diagnostic tools, deep AI application in pharmaceutical R&D (such as AstraZeneca and insitro's $1.5B collaboration), cost savings from administrative automation, and the scaling of proactive care models.
Conclusion: The Era of Responsible Healthcare AI
The AMA 2026 survey data clearly indicates that AI adoption in healthcare has crossed a critical threshold. However, high adoption rates don't mean problems have disappeared — data privacy, liability frameworks, skill degradation, and transparency remain challenges that must be seriously addressed.
For healthcare institutions and regulators across Asia-Pacific, this moment presents both opportunity and responsibility: how to drive AI innovation while building sufficiently robust governance frameworks to ensure AI truly serves patients' best interests will be the central issue for the coming years.
